Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-11-26

Clinical Trial Update: Clopidogrel and Aspirin for the Treatment of Polycythemia Vera [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating the combination of clopidogrel and aspirin for polycythemia vera was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Plavix (clopidogrel)

Snippet

Sponsor: Ronald Hoffman | Conditions: Polycythemia Vera | Phase 2 | Status: WITHDRAWN